MX2009005504A - Derivados de espiro piperidina como antagonistas del receptor via. - Google Patents

Derivados de espiro piperidina como antagonistas del receptor via.

Info

Publication number
MX2009005504A
MX2009005504A MX2009005504A MX2009005504A MX2009005504A MX 2009005504 A MX2009005504 A MX 2009005504A MX 2009005504 A MX2009005504 A MX 2009005504A MX 2009005504 A MX2009005504 A MX 2009005504A MX 2009005504 A MX2009005504 A MX 2009005504A
Authority
MX
Mexico
Prior art keywords
spiro
sup
receptor antagonists
piperidine derivatives
via receptor
Prior art date
Application number
MX2009005504A
Other languages
English (en)
Inventor
Mark Rogers-Evans
Raffaello Masciadri
Patrick Schnider
Hasane Ratni
Caterina Bissantz
Christophe Grundschober
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX2009005504A publication Critical patent/MX2009005504A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Abstract

La presente invención se refiere a nuevos derivados de indol-2-il-carbonil-espiro-piperidina que actúan como antagonistas del receptor V1a, su manufactura, composiciones farmacéuticas que los contienen y a su uso como medicamentos. Los compuestos activos de la presente invención son útiles para la prevención y/o tratamiento de ansiedad, trastornos depresivos y otras enfermedades. Los compuestos de la presente invención se representan mediante la fórmula general (I) en donde R1 a R11, X e Y son como se definió en la descripción.
MX2009005504A 2006-12-07 2007-11-29 Derivados de espiro piperidina como antagonistas del receptor via. MX2009005504A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06125634 2006-12-07
PCT/EP2007/062985 WO2008068185A1 (en) 2006-12-07 2007-11-29 Spiro-piperidine derivatives as via receptor antagonists

Publications (1)

Publication Number Publication Date
MX2009005504A true MX2009005504A (es) 2009-06-03

Family

ID=39295880

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009005504A MX2009005504A (es) 2006-12-07 2007-11-29 Derivados de espiro piperidina como antagonistas del receptor via.

Country Status (21)

Country Link
US (3) US8202993B2 (es)
EP (1) EP2102207B1 (es)
JP (1) JP2010511661A (es)
KR (1) KR101050568B1 (es)
CN (1) CN101547923A (es)
AR (1) AR064135A1 (es)
AT (1) ATE469900T1 (es)
AU (1) AU2007328995B2 (es)
BR (1) BRPI0720004A2 (es)
CA (1) CA2670674A1 (es)
CL (1) CL2007003482A1 (es)
DE (1) DE602007006990D1 (es)
ES (1) ES2344131T3 (es)
IL (1) IL198544A (es)
MX (1) MX2009005504A (es)
NO (1) NO20091830L (es)
PE (1) PE20081252A1 (es)
RU (1) RU2009119394A (es)
TW (1) TW200838518A (es)
WO (1) WO2008068185A1 (es)
ZA (1) ZA200903496B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2009006454A (es) 2006-12-22 2009-06-26 Hoffmann La Roche Derivados de espiro-piperidina.
SI2285808T1 (sl) 2008-04-29 2014-03-31 Novartis Ag Spiro-indolni derivati za zdravljenje parazitskih bolezni
EA201790919A1 (ru) * 2014-11-14 2017-08-31 Ф. Хоффманн-Ля Рош Аг Спиротиазолоны
EP3414247B1 (en) * 2016-02-08 2021-04-21 F. Hoffmann-La Roche AG Spiroindolinones as ddr1 inhibitors
US10538530B2 (en) 2017-09-05 2020-01-21 Blackthorn Therapeutics, Inc. Vasopressin receptor antagonists and products and methods related thereto

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3370091A (en) * 1964-06-15 1968-02-20 Hoffmann La Roche 2 aminobenzhydrylhalides
US3531467A (en) * 1966-12-23 1970-09-29 Hoffmann La Roche Process for the preparation of 2,3,4,5-tetrahydro - 5 - aryl - 1h - 1,4 - benzodiazepine derivatives
US4209625A (en) * 1977-04-21 1980-06-24 American Hoechst Corporation Spiro[indoline-3,4'-piperidine]s
DE3818830A1 (de) 1988-06-03 1989-12-14 Boehringer Mannheim Gmbh Bicyclische carboxamide, verfahren zu ihrer herstellung, deren vorstufen, und diese verbindungen enthaltende arzneimittel
EP0450761A1 (en) 1990-03-02 1991-10-09 Merck & Co. Inc. Spirocyclic oxytocin antagonists
DK78692D0 (da) 1992-06-12 1992-06-12 Lundbeck & Co As H Dimere piperidin- og piperazinderivater
AU5292393A (en) 1992-10-07 1994-04-26 Merck & Co., Inc. Tocolytic oxytocin receptor antagonists
US5670509A (en) * 1993-09-27 1997-09-23 Merck & Co., Inc. Tocolytic oxytocin receptor antagonists
IT1271026B (it) 1994-10-21 1997-05-26 Isagro Ricerca Srl Derivati dell'acido b-amminopropionico ad attivita' fungicida
US5576321A (en) 1995-01-17 1996-11-19 Eli Lilly And Company Compounds having effects on serotonin-related systems
CN1208412A (zh) 1995-12-14 1999-02-17 麦克公司 促性腺激素释放激素拮抗剂
GB9601724D0 (en) * 1996-01-29 1996-03-27 Merck Sharp & Dohme Therapeutic agents
US6166209A (en) 1997-12-11 2000-12-26 Hoffmann-La Roche Inc. Piperidine derivatives
CO5150201A1 (es) 1998-09-07 2002-04-29 Hoffmann La Roche Derivados de piperidina
TWI279402B (en) 1999-08-20 2007-04-21 Banyu Pharma Co Ltd Spiro compounds having NPY antagonistic activities and agents containing the same
GB0003397D0 (en) 2000-02-14 2000-04-05 Merck Sharp & Dohme Therapeutic agents
RU2261250C2 (ru) 2000-05-12 2005-09-27 Солвей Фармасьютикалс Б.В. Соединения пиперазина и пиперидина
ATE266031T1 (de) 2000-09-29 2004-05-15 Lilly Co Eli Verfahren und verbindungen zur behandlung proliferativer erkrankungen
EP1450796B1 (en) 2001-11-27 2008-04-09 F. Hoffmann-La Roche Ag Benzothiazole derivatives
FR2833948B1 (fr) 2001-12-21 2004-02-06 Sod Conseils Rech Applic Nouveaux derives de benzimidazole et leur utilisation en tant que medicament
US20040152741A1 (en) 2002-09-09 2004-08-05 Nps Allelix Corporation Arylglycine derivatives and their use as glycine transport inhibitors
WO2004026855A1 (en) 2002-09-20 2004-04-01 H. Lundbeck A/S Method for manufacture of dihydroisobenzofuran derivatives
EP1551811A1 (en) 2002-10-17 2005-07-13 Amgen Inc. Benzimidazole derivatives and their use as vanilloid receptor ligands
WO2004069809A1 (en) 2003-02-03 2004-08-19 Janssen Pharmaceutica N.V. Mercaptoimidazoles as ccr2 receptor antagonists
US7244852B2 (en) * 2003-02-27 2007-07-17 Abbott Laboratories Process for preparing 2-methylpyrrolidine and specific enantiomers thereof
EP1615698B1 (en) * 2003-04-11 2010-09-29 High Point Pharmaceuticals, LLC New amide derivatives and pharmaceutical use thereof
EP1682136A4 (en) 2003-11-04 2009-06-03 Elixir Pharmaceuticals Inc THERAPEUTIC COMPOUNDS AND CORRESPONDING USES THEREOF
KR100854872B1 (ko) * 2003-12-22 2008-08-28 화이자 인코포레이티드 바소프레신 길항제로서의 트리아졸 유도체
EP1716148A2 (en) 2003-12-23 2006-11-02 Arena Pharmaceuticals, Inc. Novel spiroindoline or spiroisoquinoline compounds, methods of use and compositions thereof
GB0400700D0 (en) * 2004-01-13 2004-02-18 Pfizer Ltd Compounds useful in therapy
WO2006013048A1 (en) 2004-08-05 2006-02-09 F.Hoffmann-La Roche Ag Indole, indazole or indoline derivatives
US8138342B2 (en) 2004-10-12 2012-03-20 High Point Pharmacueticals, LLC 11β-hydroxysteroid dehydrogenase type 1 active spiro compounds
US8599298B2 (en) * 2004-10-13 2013-12-03 Sony Corporation Reproduction apparatus, imaging apparatus, screen display method, and user interface
EP1885713A1 (en) 2005-05-18 2008-02-13 Pfizer Limited 1, 2, 4 -triazole derivatives as vasopressin antagonists
US8190027B2 (en) 2006-07-12 2012-05-29 Tellabs Operations, Inc. Multifunctional and reconfigurable optical node and optical network
CA2615726C (en) * 2005-07-14 2014-05-27 Caterina Bissantz Indol-3-yl-carbonyl-spiro-piperidine derivatives as v1a receptor antagonists
WO2007028638A1 (en) 2005-09-09 2007-03-15 Euro-Celtique S.A. Fused and spirocycle compounds and the use thereof
MX2009006454A (es) * 2006-12-22 2009-06-26 Hoffmann La Roche Derivados de espiro-piperidina.
ATE486877T1 (de) * 2006-12-29 2010-11-15 Hoffmann La Roche Azaspiroderivate
CN101583615B (zh) * 2007-01-12 2012-07-04 弗·哈夫曼-拉罗切有限公司 螺哌啶甘氨酰胺衍生物

Also Published As

Publication number Publication date
AU2007328995B2 (en) 2012-04-26
EP2102207A1 (en) 2009-09-23
US20080146568A1 (en) 2008-06-19
AU2007328995A1 (en) 2008-06-12
TW200838518A (en) 2008-10-01
ZA200903496B (en) 2010-03-31
BRPI0720004A2 (pt) 2013-12-17
WO2008068185A1 (en) 2008-06-12
EP2102207B1 (en) 2010-06-02
KR101050568B1 (ko) 2011-07-19
IL198544A0 (en) 2010-02-17
DE602007006990D1 (de) 2010-07-15
JP2010511661A (ja) 2010-04-15
PE20081252A1 (es) 2008-09-04
ES2344131T3 (es) 2010-08-18
CA2670674A1 (en) 2008-06-12
CN101547923A (zh) 2009-09-30
AR064135A1 (es) 2009-03-18
KR20090079255A (ko) 2009-07-21
ATE469900T1 (de) 2010-06-15
US20080139554A1 (en) 2008-06-12
RU2009119394A (ru) 2011-01-20
IL198544A (en) 2012-06-28
NO20091830L (no) 2009-07-06
CL2007003482A1 (es) 2008-07-04
US20080139553A1 (en) 2008-06-12
US8202993B2 (en) 2012-06-19

Similar Documents

Publication Publication Date Title
WO2008080844A9 (en) Azaspiro derivatives
MX2009005507A (es) Derivados de espiro-piperidina.
MX2009007411A (es) Derivados de espiropiperidina-glicinamida.
NO20074592L (no) Acetylenyl-pyrazolo-pyrimidinderivater som mGluR2-antagonister
MX2009006540A (es) Derivados de ester y amida de indazolilo para el tratamiento de enfermedades mediadas por un receptor de glucocorticoides.
MX2010005861A (es) Agonistas novedosos de los receptores de glucocorticoides.
GB0625648D0 (en) Compounds
MY147588A (en) (3-amino-1,2,3,4-tetrahydro-9h-carbazol-9-yl)-acetic acid derivatives
MX2012007273A (es) Pteridinonas como inhibidores de la quinasa tipo polo.
TW200621262A (en) New dihydropteridione derivatives, process for their manufacture and their use as medicament
DK1725536T3 (da) Imidazolin-derivater med CB1-antagonistisk aktivitet
GEP20135744B (en) Quinuclidine carbonate derivatives and medicinal compositions containing the same
TW200731975A (en) Novel combinations of medicaments for the treatment of respiratory diseases
MX2009006454A (es) Derivados de espiro-piperidina.
MY183111A (en) 3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9h-carbazole derivatives and their use as prostaglandin d2 receptor modulators
MX2009005544A (es) Indoles.
TW200640465A (en) New pharmaceutically active compounds for the treatment of respiratory diseases
MX2009005541A (es) Indoles que actuan como antagonistas del receptor v1a.
MX2009005504A (es) Derivados de espiro piperidina como antagonistas del receptor via.
MX2009006446A (es) Derivados de espiro-piperidina.
MX2009006920A (es) Indoles.
ATE453638T1 (de) Amidinderivate von 2-heteroarylchinazolinen und chinolinen; wirksame analgetika und entzündungshemmende mittel
UA95861C2 (en) Glucocorticoid receptor agonists
UA98126C2 (ru) Производные индазолильного эстера и амида для лечения расстройств, опосредованных глюкокортикоидным рецептором
UA84737C2 (ru) Производные имидазолина с антагонистической активностью относительно cb1

Legal Events

Date Code Title Description
HH Correction or change in general
FG Grant or registration